This report contains market size and forecasts of AI Pharma in Global, including the following market information:
Global AI Pharma Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global AI Pharma market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Self-developed Oipeline Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of AI Pharma include Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schr?dinger, Lantern Pharma and XtalPi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the AI Pharma companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global AI Pharma Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global AI Pharma Market Segment Percentages, by Type, 2021 (%)
Self-developed Oipeline
Contract Research Organization (CRO)
Other
Global AI Pharma Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global AI Pharma Market Segment Percentages, by Application, 2021 (%)
Preclinical Stage (Optimization of Lead Compounds, etc.)
Clinical Trial Phase (Predicting Treatment Outcome, etc.)
Global AI Pharma Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global AI Pharma Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AI Pharma revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies AI Pharma revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recursion
Insilico Medicine
Exscientia
BenevolentAI
Atomwise
Roivant Sciences
Schr?dinger
Lantern Pharma
XtalPi
Landos Biopharma
Relay Therapeutics
Accutar Biotech
Deep Genomics
Oncocross
AI Therapeutics
BioMap
METiS Pharmaceuticals
NeoX Biotech
StoneWise
Deep Intelligent Pharma
Gigaceuticals
Chemical.AI
Artivila
Galixir
Xbiome
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 AI Pharma Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global AI Pharma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global AI Pharma Overall Market Size
2.1 Global AI Pharma Market Size: 2021 VS 2028
2.2 Global AI Pharma Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top AI Pharma Players in Global Market
3.2 Top Global AI Pharma Companies Ranked by Revenue
3.3 Global AI Pharma Revenue by Companies
3.4 Top 3 and Top 5 AI Pharma Companies in Global Market, by Revenue in 2021
3.5 Global Companies AI Pharma Product Type
3.6 Tier 1, Tier 2 and Tier 3 AI Pharma Players in Global Market
3.6.1 List of Global Tier 1 AI Pharma Companies
3.6.2 List of Global Tier 2 and Tier 3 AI Pharma Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global AI Pharma Market Size Markets, 2021 & 2028
4.1.2 Self-developed Oipeline
4.1.3 Contract Research Organization (CRO)
4.1.4 Other
4.2 By Type - Global AI Pharma Revenue & Forecasts
4.2.1 By Type - Global AI Pharma Revenue, 2017-2022
4.2.2 By Type - Global AI Pharma Revenue, 2023-2028
4.2.3 By Type - Global AI Pharma Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global AI Pharma Market Size, 2021 & 2028
5.1.2 Preclinical Stage (Optimization of Lead Compounds, etc.)
5.1.3 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
5.2 By Application - Global AI Pharma Revenue & Forecasts
5.2.1 By Application - Global AI Pharma Revenue, 2017-2022
5.2.2 By Application - Global AI Pharma Revenue, 2023-2028
5.2.3 By Application - Global AI Pharma Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global AI Pharma Market Size, 2021 & 2028
6.2 By Region - Global AI Pharma Revenue & Forecasts
6.2.1 By Region - Global AI Pharma Revenue, 2017-2022
6.2.2 By Region - Global AI Pharma Revenue, 2023-2028
6.2.3 By Region - Global AI Pharma Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America AI Pharma Revenue, 2017-2028
6.3.2 US AI Pharma Market Size, 2017-2028
6.3.3 Canada AI Pharma Market Size, 2017-2028
6.3.4 Mexico AI Pharma Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe AI Pharma Revenue, 2017-2028
6.4.2 Germany AI Pharma Market Size, 2017-2028
6.4.3 France AI Pharma Market Size, 2017-2028
6.4.4 U.K. AI Pharma Market Size, 2017-2028
6.4.5 Italy AI Pharma Market Size, 2017-2028
6.4.6 Russia AI Pharma Market Size, 2017-2028
6.4.7 Nordic Countries AI Pharma Market Size, 2017-2028
6.4.8 Benelux AI Pharma Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia AI Pharma Revenue, 2017-2028
6.5.2 China AI Pharma Market Size, 2017-2028
6.5.3 Japan AI Pharma Market Size, 2017-2028
6.5.4 South Korea AI Pharma Market Size, 2017-2028
6.5.5 Southeast Asia AI Pharma Market Size, 2017-2028
6.5.6 India AI Pharma Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America AI Pharma Revenue, 2017-2028
6.6.2 Brazil AI Pharma Market Size, 2017-2028
6.6.3 Argentina AI Pharma Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa AI Pharma Revenue, 2017-2028
6.7.2 Turkey AI Pharma Market Size, 2017-2028
6.7.3 Israel AI Pharma Market Size, 2017-2028
6.7.4 Saudi Arabia AI Pharma Market Size, 2017-2028
6.7.5 UAE AI Pharma Market Size, 2017-2028
7 Players Profiles
7.1 Recursion
7.1.1 Recursion Corporate Summary
7.1.2 Recursion Business Overview
7.1.3 Recursion AI Pharma Major Product Offerings
7.1.4 Recursion AI Pharma Revenue in Global Market (2017-2022)
7.1.5 Recursion Key News
7.2 Insilico Medicine
7.2.1 Insilico Medicine Corporate Summary
7.2.2 Insilico Medicine Business Overview
7.2.3 Insilico Medicine AI Pharma Major Product Offerings
7.2.4 Insilico Medicine AI Pharma Revenue in Global Market (2017-2022)
7.2.5 Insilico Medicine Key News
7.3 Exscientia
7.3.1 Exscientia Corporate Summary
7.3.2 Exscientia Business Overview
7.3.3 Exscientia AI Pharma Major Product Offerings
7.3.4 Exscientia AI Pharma Revenue in Global Market (2017-2022)
7.3.5 Exscientia Key News
7.4 BenevolentAI
7.4.1 BenevolentAI Corporate Summary
7.4.2 BenevolentAI Business Overview
7.4.3 BenevolentAI AI Pharma Major Product Offerings
7.4.4 BenevolentAI AI Pharma Revenue in Global Market (2017-2022)
7.4.5 BenevolentAI Key News
7.5 Atomwise
7.5.1 Atomwise Corporate Summary
7.5.2 Atomwise Business Overview
7.5.3 Atomwise AI Pharma Major Product Offerings
7.5.4 Atomwise AI Pharma Revenue in Global Market (2017-2022)
7.5.5 Atomwise Key News
7.6 Roivant Sciences
7.6.1 Roivant Sciences Corporate Summary
7.6.2 Roivant Sciences Business Overview
7.6.3 Roivant Sciences AI Pharma Major Product Offerings
7.6.4 Roivant Sciences AI Pharma Revenue in Global Market (2017-2022)
7.6.5 Roivant Sciences Key News
7.7 Schr